Second Patient News Today

Red Lobster Files for Bankruptcy The largest seafood restaurant chain in the U.S. will sell its business to an entity formed and controlled by its existing term lenders. Neuralink Gets FDA...

Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform Hims & Hers Health is adding GLP-1 injections to its weight loss offering, a move that can bolster the companys... -May 20, 2024 at 11:16 am EDT - MarketScreener

Johnson Controls Stock Pops on Report Activist Investor Has Built Up Its Stake A report says Elliott Investment Management has been building a position in the air conditioning and building...

Johnson Controls Stock Pops on Report Activist Investor Has Built Up Its Stake A report says Elliott Investment Management has been building a position in the air conditioning and building... -May 20, 2024 at 03:16 pm EDT - MarketScreener

Palo Alto Networks stock falls after earnings as forecast fails to impress The stock was down about 10% in after-hours action Monday. It lost 28% in the session after the last earnings report.... -May 20, 2024 at 05:15 pm EDT - MarketScreener

Marks the Second Patient to Clinically Benefit from Administration of Voriconazole Inhalation Powder Using Thin Film Freezing-Based Technology Positive Results from First Patient Treated with TFF... | November 1, 2022

According to current statistics from the University of Michigan, approximately one in seven Americans has some form of dementia.

A case study of a patient with progressive pancreatic cancer singles out T-cell receptor transduction therapy as a promising new approach for others with the same mutation and the right allele.